• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

PNNL waives fee to test-drive portfolio of intellectual property

Bioengineer by Bioengineer
June 11, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Special exploratory license agreement designed to spur economic recovery

IMAGE

Credit: Andrea Starr | Pacific Northwest National Laboratory

RICHLAND, Wash. — As businesses of all sizes weather today’s tough economy, the U.S. Department of Energy’s Pacific Northwest National Laboratory is offering its entire portfolio of patented technologies on a research trial basis–at no cost–to spur economic development and ultimately create new jobs.

Dozens of technologies could be deployed across U.S. markets spanning everything from analytical instruments, human health and agriculture to advanced manufacturing, cybersecurity and renewable energy. Through the six-month trial period, businesses can try out PNNL’s technologies.

“Our goal is to quickly and inexpensively put these innovations into the hands of companies, entrepreneurs and investors where they can be productized and deployed,” PNNL Director of Technology Deployment and Outreach Lee Cheatham explained.

Some of PNNL’s intellectual property could be applied to help with the COVID-19 pandemic. For example, one of the most recent additions to the portfolio is a coating called ElastiDry. This inexpensive and stretchable superhydrophobic material could be included during the manufacture of latex gloves–or other protective clothing–to make personal protective equipment impenetrable to deadly viruses.

No-cost trial period for on-site testing

From now through December 31, 2020, the standard $1,000 fee will be waived for organizations and entrepreneurs interested in signing a nonexclusive exploratory license agreement, which means more than one organization can hold a license for the same technology. The agreement allows entrepreneurs and organizations to test a technology within their own product lines before entering into a formal licensing agreement.

Details of the special exploratory license agreement include:

  • Use of intellectual property with the option to negotiate a commercial license for the patent; the agreement holds the licensee’s access to intellectual property during the exploratory period.
  • A simplified, two-page form.
  • Simplified terms.
  • Rapid execution–PNNL expects to turn around licenses in less than two weeks.

“As a Department of Energy national laboratory, one of our primary missions is to transfer technologies developed through federal funding to the marketplace, where they can make a real difference,” Cheatham said. “As our nation struggles with how to jump-start our economy, now more than ever, we want to speed the process.”

###

To learn more, visit PNNL’s Exploratory License page.

Media Contact
Tom Rickey
[email protected]

Original Source

https://www.pnnl.gov/news-media/pnnl-waives-fee-test-drive-portfolio-intellectual-property

Tags: Business/EconomicsIntellectual PropertyLicenses/PatentsTechnology Transfer
Share12Tweet8Share2ShareShareShare2

Related Posts

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

February 7, 2026

Digital Health Perspectives from Baltic Sea Experts

February 7, 2026

Florida Cane Toad: Complex Spread and Selective Evolution

February 7, 2026

Exploring Decision-Making in Dementia Caregivers’ Mobility

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

Digital Health Perspectives from Baltic Sea Experts

Florida Cane Toad: Complex Spread and Selective Evolution

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.